IL-23/IL-17 Pathway and Foxp3 in Chronic Hepatitis B
Author Information
Author(s): Wang Qinghong, Zheng Yanhua, Huang Zemin, Tian Yi, Zhou Jijun, Mao Qing, Wu Yuzhang, Ni Bing
Primary Institution: Ministry of Education Key Laboratory of Child Development and Disorders, Pediatric Research Institute, Children's Hospital of Chongqing Medical University
Hypothesis
The study investigates the correlation between Foxp3 expression and the IL-23/IL-17 pathway in chronic hepatitis B patients.
Conclusion
The study found that increased Foxp3 expression and IL-23/IL-17 pathway activity in HBV-infected livers suggest ineffective suppression of inflammation by the immune system.
Supporting Evidence
- Foxp3 expression was significantly higher in the liver tissues of chronic hepatitis B patients compared to healthy controls.
- The expression of IL-23/IL-17 pathway-related cytokines was significantly elevated in HBV-infected liver tissues.
- Foxp3 expression correlated positively with HBV DNA copies and HBsAg concentration in liver tissues.
Takeaway
In patients with chronic hepatitis B, a protein called Foxp3 that helps control inflammation is found in higher amounts, which is linked to a pathway that causes inflammation.
Methodology
The study analyzed blood and liver tissue samples from 110 HBV-infected patients and healthy controls, measuring Foxp3 and IL-23/IL-17 pathway-related cytokines using qPCR and flow cytometry.
Potential Biases
Potential bias may arise from the selection of patients and the lack of control for confounding factors.
Limitations
The study is limited by its observational nature and the specific patient population studied.
Participant Demographics
The study included 110 HBV-infected patients (39 with acute-on-chronic liver failure and 71 with chronic hepatitis B) and 32 healthy controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website